A recent study shows that persistent NF-κB p65 activation promotes pro-inflammatory, pro-fibrotic and pro-apoptotic effects, and exacerbates cardiac hypertrophy and apoptosis in heart failure [32]. The gene discussed is NFKB1; the disease is cardiac hypertrophy.